As we listed in Table 3, at present, the research on “do not eat me” signal is mostly limited to targeting CD47, but other signal inhibitors such as CD24‐Fc, IMM47, and ATG‐031 have shown promising results in preclinical experiments.[254, 255] We are looking forward to their final launch, which will bring new hope to cancer patients. Here, CD47 is linked to cancer.